Indivior (OTC: INVVY)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Indivior (OTCPK: INVVY) through any online brokerage.
There are no as such competitors for Indivior.
The latest price target for Indivior (OTCPK: INVVY) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting INVVY to fall to within 12 months (a possible -78.66% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Indivior (OTCPK: INVVY) is $18.74 last updated August 12, 2022, 7:23 PM UTC.
The next Indivior (INVVY) dividend date is projected to be Thursday, September 1, 2022.
Indivior’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Indivior.
Indivior is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.